Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

Mapping Intimacies ◽

10.1111/dom.13888/v1/review5 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review4 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review2 ◽

2019 ◽

Author(s):

Per Wändell

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review3 ◽

2019 ◽

Author(s):

Luis M. Ruilope

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Decision letter for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/decision1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/dom.13888 ◽

2019 ◽

Vol 22 (2) ◽

pp. 203-211 ◽

Author(s):

Edoardo Mannucci ◽

Ilaria Dicembrini ◽

Besmir Nreu ◽

Matteo Monami

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Decision letter for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v3/decision1 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review6 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review4 ◽

2019 ◽

Keyword(s):

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text